首页> 外文期刊>Antiviral Research >Prevention of HIV-1 infection by platinum triazines.
【24h】

Prevention of HIV-1 infection by platinum triazines.

机译:预防三嗪铂对HIV-1的感染。

获取原文
获取原文并翻译 | 示例
       

摘要

To identify and explore the activity of compounds which may act as anti-HIV virucidal agents, we have investigated platinum compounds, especially those containing N-donor aromatic ligands. After screening over 70 related agents, including N-donor aromatic ligands and metal precursors, we have identified a novel class of platinum(II) complexes with 2-pyridyl-1,2,4-triazine derivatives and Pt(II) formulations with these derivatives (ptt compounds) as having the highest anti-HIV activity. The maximum activity was observed when the agents were added immediately post-infection. The ptt agents did not block cell fusion activity of HIV-1 Env proteins in cells bearing CD4X4 or CD4R5 receptors, indicating a lack of interaction with the Env protein. The ptt compounds exhibit low toxicity for human epithelial cells, and are thus promising candidates for use as microbicides or antiviral agents against HIV.
机译:为了鉴定和探索可用作抗HIV杀病毒剂的化合物的活性,我们研究了铂化合物,尤其是那些含有N-供体芳族配体的化合物。在筛选了70多种相关试剂(包括N-供体芳族配体和金属前体)后,我们确定了带有2-吡啶基-1,2,4-三嗪衍生物和Pt(II)配方的新型铂(II)配合物。具有最高的抗HIV活性的衍生物(ptt化合物)。当感染后立即添加药剂时,观察到最大活性。在携带CD4X4或CD4R5受体的细胞中,ptt剂不会阻断HIV-1 Env蛋白的细胞融合活性,表明缺乏与Env蛋白的相互作用。 ptt化合物对人上皮细胞毒性低,因此有望用作抗HIV的杀菌剂或抗病毒剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号